Bladder cancer: Present and future
Med Clin (Barc). 2017 Nov 22;149(10):449-455.
doi: 10.1016/j.medcli.2017.06.009.
Epub 2017 Jul 21.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Urología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España. Electronic address: [email protected].
- 2 Servicio de Urología, Hospital Universitari Germans Trias i Pujol, Badalona, Barcelona, España.
Abstract
Bladder cancer has a high incidence and involves high associated morbidity and mortality. Since its initial clinical suspicion, early diagnostic confirmation and multimodal treatment involve different medical specialties. For this reason, we consider it important to spread the current consensus for its management. Recent advances in immunology and Chemotherapy make it necessary to expose and reflect on future perspectives.
Keywords:
Bacilo Calmette-Guérin; Bladder cancer; Calmette-Guérin bacillus; Cistectomía; Cystectomy; Haematuria; Hematuria; Immunotherapy; Inmunoterapia; Tumor vesical; Urotelio; Urothelial.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Biomarkers, Tumor / urine
-
Combined Modality Therapy
-
Early Detection of Cancer / methods
-
Humans
-
Neoplasm Grading
-
Urinary Bladder Neoplasms / diagnosis*
-
Urinary Bladder Neoplasms / pathology
-
Urinary Bladder Neoplasms / therapy*
-
Urinary Bladder Neoplasms / urine